Literature DB >> 6425687

Care of patients with a low probability of acute myocardial infarction. Cost effectiveness of alternatives to coronary-care-unit admission.

H V Fineberg, D Scadden, L Goldman.   

Abstract

We conducted a cost-effectiveness analysis to examine the clinical and economic consequences of alternatives to admission to a coronary-care unit for patients who have a relatively low probability of acute myocardial infarction. Despite the fact that all our assumptions were slanted to favor the current standard policy of admission to a coronary-care unit, our analysis shows that admission to an intermediate-care unit providing resuscitative facilities and prophylactic lidocaine is highly cost effective. For patients with about a 5 per cent probability of infarction, admission to a coronary-care unit would cost $2.04 million per life saved and $139,000 per year of life saved, as compared with intermediate care. For the expected number of such patients annually in the United States, the cost would be $297 million to save 145 lives. At probabilities of infarction up to about 20 per cent, the incremental cost to save a year of life by choosing a coronary-care unit over an intermediate-care unit would be higher than the estimated cost of saving a year of life by treating a 40-year-old man with mild hypertension. Our results suggest that many patients who have a low risk of acute myocardial infarction would be appropriate candidates for admission to an intermediate-care unit.

Entities:  

Mesh:

Year:  1984        PMID: 6425687     DOI: 10.1056/NEJM198405173102006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  39 in total

1.  Evaluating decision aids: the next painful step.

Authors:  T H Lee
Journal:  J Gen Intern Med       Date:  1990 Nov-Dec       Impact factor: 5.128

2.  Cost effectiveness of beractant in the prevention of respiratory distress syndrome.

Authors:  R F Soll; J Jacobs; S Pashko; R Thomas
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Stress myocardial perfusion imaging for the evaluation and triage of chest pain in the emergency department: a randomized controlled trial.

Authors:  Swee Han Lim; Venkataraman Anantharaman; Felix Sundram; Edwin Shih-Yen Chan; Ee Sin Ang; Sui Lan Yo; Edward Jacob; Anthony Goh; Say Beng Tan; Terrance Chua
Journal:  J Nucl Cardiol       Date:  2013-09-13       Impact factor: 5.952

Review 4.  Cost-effectiveness of myocardial perfusion imaging: a summary of the currently available literature.

Authors:  Roger D Des Prez; Leslee J Shaw; Robert L Gillespie; Wael A Jaber; Gavin L Noble; Prem Soman; David G Wolinsky; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  It's tough to make predictions...

Authors:  Wayne Warnica
Journal:  Can J Cardiol       Date:  2007-03-15       Impact factor: 5.223

6.  A Novel Neuroscience Intermediate-Level Care Unit Model: Retrospective Analysis of Impact on Patient Flow and Safety.

Authors:  Alexandra E Quimby; Michel C F Shamy; Deanna M Rothwell; Erin Y Liu; Dar Dowlatshahi; Grant Stotts
Journal:  Neurohospitalist       Date:  2016-10-15

Review 7.  Myocardial perfusion imaging in the evaluation of chest pain in the acute care setting: Clinical and economic outcomes.

Authors:  Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

8.  The impact of the organization of high-dependency care on acute hospital mortality and patient flow for critically ill patients.

Authors:  Hannah Wunsch; David A Harrison; Andrew Jones; Kathryn Rowan
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

9.  Reflections on supply-demand mismatch in dialysis services in Ontario.

Authors:  N K Choudhry; C D Naylor
Journal:  CMAJ       Date:  1995-09-01       Impact factor: 8.262

10.  Determinants of resource utilization for patients admitted for evaluation of acute chest pain.

Authors:  I S Udvarhelyi; L Goldman; A L Komaroff; T H Lee
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.